Your browser doesn't support javascript.
loading
Urolithin A attenuates RANKL-induced osteoclastogenesis by co-regulating the p38 MAPK and Nrf2 signaling pathway.
Wei, Wei; Peng, Chenjian; Gu, Renjun; Yan, Xiwu; Ye, Jiapeng; Xu, Zhuicheng; Sheng, Xianjie; Huang, Guicheng; Guo, Yang.
Affiliation
  • Wei W; The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Peng C; Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, 210001, China.
  • Gu R; The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Yan X; The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Ye J; The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Xu Z; School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Sheng X; School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Huang G; The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Electronic address: hgc@njucm.edu.cn.
  • Guo Y; The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Electronic address: drguoyang@njucm.edu.cn.
Eur J Pharmacol ; 921: 174865, 2022 Apr 15.
Article in En | MEDLINE | ID: mdl-35231470
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Resorption / RANK Ligand Type of study: Prognostic_studies Limits: Animals Language: En Journal: Eur J Pharmacol Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Resorption / RANK Ligand Type of study: Prognostic_studies Limits: Animals Language: En Journal: Eur J Pharmacol Year: 2022 Document type: Article